RNWL
INTERNATIONAL REGISTRATION RENEWED
03/05/2026
Back to search
Official data from USPTO
OPIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
65
Latest update
03/06/2026
Trademark type
Combined
Nice classes
35, 42
Filing date
02/22/2016
Registration date
06/12/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/02/2025
Last transaction
03/06/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
IT
Examiner
TANNER, MICHAEL R
Current location
Historical data usage
Mark description
The mark consists of the stylized word "OPIS" wherein the center of the letter "O" has a stylized human face. The color dark blue appears in the letters "OPIS" as well as the depiction of the eye located on the light blue side of the human face that is closest to the letter "P". The color light blue appears in the right half of the human face. The color blue appears in the left half of the stylized human face. The color white appears in the depiction of the eye located on the blue side of the human face. Other than the color white appearing in the eye, the color white represents background, outlining, shading, and/or transparent areas and are not part of the mark.
Holders and representatives
Holders
OPIS S.r.l.
Representatives
Anna Kurian Shaw Hogan Lovells US LLP
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting in the fields of clinical research and health research; Regulatory submission management for the pharmaceutical and biotechnology industriesassisting others in preparing and filing applications for clinical trial approvalpharmaceutical and health product approval
Class 42
Research and development in the medicalpharmaceutical and biotechnological fieldsPharmaceutical research and developmentResearch and development in the pharmaceutical and biotechnology fields; Pharmaceutical products development; Conducting and monitoring clinical trials for pharmaceutical productsconducting clinical trials for othersmonitoring pharmaceutical clinical trials for others for quality control purposes; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing a searchable database in the fields of medicalpharmaceutical and biotechnological research; Database development services for others to process data collected from clinical trials; Pharmacovigilancemonitoring pharmaceutical clinical trials for others for quality control purposesconducting quality evaluation and analysisquality assurancequality control testing for others in the pharmaceutical field; Toxicology services; Contract research organization services for pharmaceutical development and clinical development and trialconducting clinical trials for others; designing and developing software for others for use in managing data in the medicalpharmaceutical and biotechnological industries
Publications
History of USPTO decisions and trademark events.
65 publications found
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
02/24/2026
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/10/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/02/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
01/02/2025
71AG
REGISTERED-SEC.71 ACCEPTED
01/02/2025
PRAN
POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
01/02/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/30/2024
ES71
TEAS SECTION 71 RECEIVED
06/04/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/12/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/04/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/13/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/13/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/13/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/13/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/13/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/09/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/09/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/09/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/09/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/09/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/09/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/06/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/19/2018
FIMP
FINAL DISPOSITION PROCESSED
09/18/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/12/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
06/12/2018
GPNX
NOTIFICATION PROCESSED BY IB
03/30/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/27/2018
PUBO
PUBLISHED FOR OPPOSITION
03/27/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/07/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/07/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/07/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/15/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
01/24/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/24/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
01/24/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/24/2018
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/18/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/13/2017
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/13/2017
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
09/05/2017
GNSF
SUBSEQUENT FINAL EMAILED
09/05/2017
CFRC
SUBSEQUENT FINAL REFUSAL WRITTEN
09/05/2017
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
08/17/2017
GNSF
SUBSEQUENT FINAL EMAILED
08/17/2017
CFRC
SUBSEQUENT FINAL REFUSAL WRITTEN
08/17/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/27/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/22/2017
GNFR
FINAL REFUSAL E-MAILED
02/22/2017
CNFR
FINAL REFUSAL WRITTEN
02/22/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/14/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/13/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/13/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/21/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/21/2016
RFNT
REFUSAL PROCESSED BY IB
07/29/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/13/2016
RFRR
REFUSAL PROCESSED BY MPU
07/13/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/13/2016
CNRT
NON-FINAL ACTION WRITTEN
07/12/2016
MAFR
APPLICATION FILING RECEIPT MAILED
07/12/2016
DOCK
ASSIGNED TO EXAMINER
07/08/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/08/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/07/2016
Continuous trademark protection
Get notified about every new filing that threatens OPIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.